These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2206 related articles for article (PubMed ID: 27256883)

  • 1. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector.
    Abudayyeh OO; Gootenberg JS; Konermann S; Joung J; Slaymaker IM; Cox DB; Shmakov S; Makarova KS; Semenova E; Minakhin L; Severinov K; Regev A; Lander ES; Koonin EV; Zhang F
    Science; 2016 Aug; 353(6299):aaf5573. PubMed ID: 27256883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection.
    East-Seletsky A; O'Connell MR; Knight SC; Burstein D; Cate JH; Tjian R; Doudna JA
    Nature; 2016 Oct; 538(7624):270-273. PubMed ID: 27669025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems.
    O'Connell MR
    J Mol Biol; 2019 Jan; 431(1):66-87. PubMed ID: 29940185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for self-cleavage prevention by tag:anti-tag pairing complementarity in type VI Cas13 CRISPR systems.
    Wang B; Zhang T; Yin J; Yu Y; Xu W; Ding J; Patel DJ; Yang H
    Mol Cell; 2021 Mar; 81(5):1100-1115.e5. PubMed ID: 33472057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Revolution Continues: Newly Discovered Systems Expand the CRISPR-Cas Toolkit.
    Murugan K; Babu K; Sundaresan R; Rajan R; Sashital DG
    Mol Cell; 2017 Oct; 68(1):15-25. PubMed ID: 28985502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches to study CRISPR RNA biogenesis and the key players involved.
    Behler J; Hess WR
    Methods; 2020 Feb; 172():12-26. PubMed ID: 31325492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for the endoribonuclease activity of the type III-A CRISPR-associated protein Csm6.
    Niewoehner O; Jinek M
    RNA; 2016 Mar; 22(3):318-29. PubMed ID: 26763118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two Distant Catalytic Sites Are Responsible for C2c2 RNase Activities.
    Liu L; Li X; Wang J; Wang M; Chen P; Yin M; Li J; Sheng G; Wang Y
    Cell; 2017 Jan; 168(1-2):121-134.e12. PubMed ID: 28086085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a.
    Liu L; Li X; Ma J; Li Z; You L; Wang J; Wang M; Zhang X; Wang Y
    Cell; 2017 Aug; 170(4):714-726.e10. PubMed ID: 28757251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Composition and Diversity of CRISPR-Cas13a Systems in the Genus
    Watanabe S; Cui B; Kiga K; Aiba Y; Tan XE; Sato'o Y; Kawauchi M; Boonsiri T; Thitiananpakorn K; Taki Y; Li FY; Azam AH; Nakada Y; Sasahara T; Cui L
    Front Microbiol; 2019; 10():2838. PubMed ID: 31921024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
    Yang H; Patel DJ
    Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein.
    Yan WX; Chong S; Zhang H; Makarova KS; Koonin EV; Cheng DR; Scott DA
    Mol Cell; 2018 Apr; 70(2):327-339.e5. PubMed ID: 29551514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel RNA-guided RNA-targeting CRISPR tool.
    Zhang D; Li Z; Yan B; Li JF
    Sci China Life Sci; 2016 Aug; 59(8):854-6. PubMed ID: 27436421
    [No Abstract]   [Full Text] [Related]  

  • 14. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA.
    Fonfara I; Richter H; Bratovič M; Le Rhun A; Charpentier E
    Nature; 2016 Apr; 532(7600):517-21. PubMed ID: 27096362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unity among the diverse RNA-guided CRISPR-Cas interference mechanisms.
    Ganguly C; Rostami S; Long K; Aribam SD; Rajan R
    J Biol Chem; 2024 Jun; 300(6):107295. PubMed ID: 38641067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA targeting with CRISPR-Cas13.
    Abudayyeh OO; Gootenberg JS; Essletzbichler P; Han S; Joung J; Belanto JJ; Verdine V; Cox DBT; Kellner MJ; Regev A; Lander ES; Voytas DF; Ting AY; Zhang F
    Nature; 2017 Oct; 550(7675):280-284. PubMed ID: 28976959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolutionary and mechanistic diversity of Type I-F CRISPR-associated transposons.
    Klompe SE; Jaber N; Beh LY; Mohabir JT; Bernheim A; Sternberg SH
    Mol Cell; 2022 Feb; 82(3):616-628.e5. PubMed ID: 35051352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions.
    Wiedenheft B; van Duijn E; Bultema JB; Waghmare SP; Zhou K; Barendregt A; Westphal W; Heck AJ; Boekema EJ; Dickman MJ; Doudna JA
    Proc Natl Acad Sci U S A; 2011 Jun; 108(25):10092-7. PubMed ID: 21536913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A scoutRNA Is Required for Some Type V CRISPR-Cas Systems.
    Harrington LB; Ma E; Chen JS; Witte IP; Gertz D; Paez-Espino D; Al-Shayeb B; Kyrpides NC; Burstein D; Banfield JF; Doudna JA
    Mol Cell; 2020 Aug; 79(3):416-424.e5. PubMed ID: 32645367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus thermophilus.
    Tamulaitis G; Kazlauskiene M; Manakova E; Venclovas Č; Nwokeoji AO; Dickman MJ; Horvath P; Siksnys V
    Mol Cell; 2014 Nov; 56(4):506-17. PubMed ID: 25458845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 111.